Aurobindo Pharma reports 12% fall in Q1 consolidated net profit

10 Aug 2018 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2018.

The company has reported a fall of 26.75% in its net profit at Rs 225.12 crore for the quarter under review as compared to Rs 307.33 crore for the same quarter in the previous year. However, total income of the company increased by 16.44% at Rs 2,561.64 crore for Q1FY19 as compared Rs 2,199.96 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 12.12% in its net profit at Rs 455.66 crore for the quarter under review as compared to Rs 518.51 crore for the same quarter in the previous year. However, total income of the company increased by 16.03% at Rs 4,294.00 crore for Q1FY19 as compared Rs 3,700.84 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1198.50 -8.30 (-0.69%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×